VOLITIONRX LTD — Director's Dealing 2020

Apr 6, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-03-30

Reporting Person: Kway Jasmine (CEO-Singapore Volition)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5400	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.8	2023-01-01	Common Stock (50000)		Direct
Stock Option (Right to Buy)	$4	2024-01-23	Common Stock (50000)		Direct
Stock Option (Right to Buy)	$3.25	2025-02-11	Common Stock (50000)		Direct